Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - PSYCHEMEDICS CORP | exh_322.htm |
| EX-32.1 - EXHIBIT 32.1 - PSYCHEMEDICS CORP | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - PSYCHEMEDICS CORP | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - PSYCHEMEDICS CORP | exh_311.htm |
| EX-24 - EXHIBIT 24 - PSYCHEMEDICS CORP | exh_24.htm |
| EX-21.1 - EXHIBIT 21.1 - PSYCHEMEDICS CORP | exh_211.htm |
| EX-10.12.3 - EXHIBIT 10.12.3 - PSYCHEMEDICS CORP | exh_10123.htm |
| 10-K - FORM 10-K - PSYCHEMEDICS CORP | f10k_031218p.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
Psychemedics Corporation
Acton, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-134974, 333-174531 and 333-211745) of Psychemedics Corporation of our reports dated March 16, 2018, relating to the consolidated financial statements and the effectiveness of Psychemedics Corporation’s internal control over financial reporting as of December 31, 2017 (which report expresses an adverse opinion on the effectiveness of Psychemedics Corporation’s internal control over financial reporting because of a material weakness), which appear in this Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 16, 2018